Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Novel Vanadium-Loaded Ordered Collagen Scaffold Promotes Osteochondral Differentiation of Bone Marrow Progenitor Cells.

Cortizo AM, Ruderman G, Mazzini FN, Molinuevo MS, Mogilner IG.

Int J Biomater. 2016;2016:1486350. doi: 10.1155/2016/1486350. Epub 2016 May 11.

2.

Metformin revisited: Does this regulator of AMP-activated protein kinase secondarily affect bone metabolism and prevent diabetic osteopathy.

McCarthy AD, Cortizo AM, Sedlinsky C.

World J Diabetes. 2016 Mar 25;7(6):122-33. doi: 10.4239/wjd.v7.i6.122. Review.

3.

Ultrasonic compatibilization of polyelectrolyte complex based on polysaccharides for biomedical applications.

Belluzo MS, Medina LF, Cortizo AM, Cortizo MS.

Ultrason Sonochem. 2016 May;30:1-8. doi: 10.1016/j.ultsonch.2015.11.022. Epub 2015 Nov 23.

PMID:
26703196
4.

Strontium ranelate stimulates the activity of bone-specific alkaline phosphatase: interaction with Zn(2+) and Mg (2+).

Fernández JM, Molinuevo MS, McCarthy AD, Cortizo AM.

Biometals. 2014 Jun;27(3):601-7. doi: 10.1007/s10534-014-9733-8. Epub 2014 Apr 16.

PMID:
24737106
5.

Effects of a metabolic syndrome induced by a fructose-rich diet on bone metabolism in rats.

Felice JI, Gangoiti MV, Molinuevo MS, McCarthy AD, Cortizo AM.

Metabolism. 2014 Feb;63(2):296-305. doi: 10.1016/j.metabol.2013.11.002. Epub 2013 Nov 7.

PMID:
24355623
6.

Insulin-deficient diabetes-induced bone microarchitecture alterations are associated with a decrease in the osteogenic potential of bone marrow progenitor cells: preventive effects of metformin.

Tolosa MJ, Chuguransky SR, Sedlinsky C, Schurman L, McCarthy AD, Molinuevo MS, Cortizo AM.

Diabetes Res Clin Pract. 2013 Aug;101(2):177-86. doi: 10.1016/j.diabres.2013.05.016. Epub 2013 Jun 24.

PMID:
23806481
7.

Strontium ranelate prevents the deleterious action of advanced glycation endproducts on osteoblastic cells via calcium channel activation.

Fernández JM, Molinuevo MS, Sedlinsky C, Schurman L, Cortizo AM, McCarthy AD.

Eur J Pharmacol. 2013 Apr 15;706(1-3):41-7. doi: 10.1016/j.ejphar.2013.02.042. Epub 2013 Mar 13.

PMID:
23499695
8.

Morphological changes induced by advanced glycation endproducts in osteoblastic cells: effects of co-incubation with alendronate.

Gangoiti MV, Anbinder PS, Cortizo AM, McCarthy AD.

Acta Histochem. 2013 Sep;115(7):649-57. doi: 10.1016/j.acthis.2013.01.004. Epub 2013 Mar 5.

PMID:
23465485
9.

Chlorhexidine delivery system from titanium/polybenzyl acrylate coating: evaluation of cytotoxicity and early bacterial adhesion.

Cortizo MC, Oberti TG, Cortizo MS, Cortizo AM, Fernández Lorenzo de Mele MA.

J Dent. 2012 Apr;40(4):329-37. doi: 10.1016/j.jdent.2012.01.008. Epub 2012 Jan 25.

PMID:
22305778
10.

Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats.

Sedlinsky C, Molinuevo MS, Cortizo AM, Tolosa MJ, Felice JI, Sbaraglini ML, Schurman L, McCarthy AD.

Eur J Pharmacol. 2011 Oct 15;668(3):477-85. doi: 10.1016/j.ejphar.2011.07.033. Epub 2011 Aug 5.

PMID:
21839072
11.

Development of an osteoconductive PCL-PDIPF-hydroxyapatite composite scaffold for bone tissue engineering.

Fernandez JM, Molinuevo MS, Cortizo MS, Cortizo AM.

J Tissue Eng Regen Med. 2011 Jun;5(6):e126-35. doi: 10.1002/term.394. Epub 2011 Feb 10.

PMID:
21312338
12.

Characterization of poly(epsilon-caprolactone)/polyfumarate blends as scaffolds for bone tissue engineering.

Fernandez JM, Molinuevo MS, Cortizo AM, McCarthy AD, Cortizo MS.

J Biomater Sci Polym Ed. 2010;21(10):1297-312. doi: 10.1163/092050609X12517190417632. Epub 2010 Jun 8.

PMID:
20534186
13.

Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies.

Molinuevo MS, Schurman L, McCarthy AD, Cortizo AM, Tolosa MJ, Gangoiti MV, Arnol V, Sedlinsky C.

J Bone Miner Res. 2010 Feb;25(2):211-21. doi: 10.1359/jbmr.090732.

14.

Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells.

Gangoiti MV, Cortizo AM, Arnol V, Felice JI, McCarthy AD.

Eur J Pharmacol. 2008 Dec 14;600(1-3):140-7. doi: 10.1016/j.ejphar.2008.10.031. Epub 2008 Oct 21.

PMID:
18973752
15.

Biocompatibility and biodegradation of polyester and polyfumarate based-scaffolds for bone tissue engineering.

Cortizo MS, Molinuevo MS, Cortizo AM.

J Tissue Eng Regen Med. 2008 Jan;2(1):33-42. doi: 10.1002/term.62.

PMID:
18273918
16.

Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells.

Schurman L, McCarthy AD, Sedlinsky C, Gangoiti MV, Arnol V, Bruzzone L, Cortizo AM.

Exp Clin Endocrinol Diabetes. 2008 Jun;116(6):333-40. doi: 10.1055/s-2007-992786.

PMID:
18273753
17.

Regulation of advanced glycation end product (AGE) receptors and apoptosis by AGEs in osteoblast-like cells.

Mercer N, Ahmed H, Etcheverry SB, Vasta GR, Cortizo AM.

Mol Cell Biochem. 2007 Dec;306(1-2):87-94. Epub 2007 Jul 28.

PMID:
17660952
18.

Vanadium(IV) complexes inhibit adhesion, migration and colony formation of UMR106 osteosarcoma cells.

Molinuevo MS, Cortizo AM, Etcheverry SB.

Cancer Chemother Pharmacol. 2008 Apr;61(5):767-73. Epub 2007 Jun 19.

PMID:
17576559
19.

Alendronate induces anti-migratory effects and inhibition of neutral phosphatases in UMR106 osteosarcoma cells.

Molinuevo MS, Bruzzone L, Cortizo AM.

Eur J Pharmacol. 2007 May 7;562(1-2):28-33. Epub 2007 Feb 8.

PMID:
17341419
20.

Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture.

Cortizo AM, Sedlinsky C, McCarthy AD, Blanco A, Schurman L.

Eur J Pharmacol. 2006 Apr 24;536(1-2):38-46. Epub 2006 Feb 28.

PMID:
16564524
Items per page

Supplemental Content

Loading ...
Write to the Help Desk